Tuesday, December 5, 2017

ASH: BPMC To Make A Mark; FATE So Far, So Good; Watch Out For SYRS, BIVV

Here's another list of companies that will be presenting new data or updated analyses from their hematology clinical trials.

from RTT - Biotech http://ift.tt/2iVL3CM
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)